DOXORUBICIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML

Approval Number

SIN14969P

Drug Name

Product Name

DOXORUBICIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML

Approval Date

March 21, 2016

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION, CONCENTRATE

Route of Administration

INTRAVENOUS, INTRAVESICAL

Medical Information

ATC Code

L01DB01

ATC Item Name

doxorubicin

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

S.C. SINDAN-PHARMA S.R.L

Active Ingredients

Ingredient Name

Doxorubicin hydrochloride

Strength

2mg/ml

Drug MonographDoxorubicin

AI-Powered Research

Premium Access

DOXORUBICIN-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients